throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`DEPUY SYNTHES SALES, INC. and DEPUY
`
`SYNTHES PRODUCTS, LLC,
`
`Petitioner
`
`v.
`
`Patent Owner of
`U.S. Patent No. 6,099,531 to Bonutti
`Appl. No. 09/137,443 filed Aug. 20, 1998
`Issued Aug. 8, 2000
`
`IPR Trial No.
`
`TBD
`
`DECLARATION OF CARL R. McMILLIN, Ph.D., IN SUPPORT OF
`PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO.
`6,099,531 PURSUANT TO 35 U.S.C. § 312 AND 37 C.F.R. § 42.108
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`1 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`1.
`
`2.
`
`I, Carl. R. McMillin, Ph.D., declare as follows:
`
`I understand that DePuy Synthes Sales, Inc. and DePuy Synthes
`
`Products, LLC (collectively “Synthes”) are petitioning for inter partes review of
`
`U.S. Patent No. 6,099,531 (“the ‘531 patent”) and the cancellation of Independent
`
`Claim 105 (“the Challenged Claims”) of the ‘531 patent. I submit this declaration
`
`in support of the Synthes petition.
`
`3.
`
`I understand that the ‘531 patent issued on August 8, 2000, from an
`
`application which claims priority to August 20, 1998. My statements and opinions
`
`in this declaration are intended to reflect the knowledge in the art that existed as of
`
`August 20, 1998
`
`4.
`
`I am being compensated for my time at my standard rate of $500 per
`
`hour plus expenses. My compensation is not dependent in any way upon the
`
`outcome of the Synthes petition
`
`
`I.
`
`PROFESSIONAL BACKGROUND
`
`5.
`
`I am currently an Independent Consultant and President of Synthetic
`
`Body Parts, Inc. in Brecksville, Ohio. I have held this position since 1997. From
`
`1989-1997, I held positions as Senior Scientist, Director of Polymer Laboratory
`
`and Director of R&D at AcroMed Corporation in Cleveland, Ohio. From 1983-
`
`1989, I was an Associate Professor in the Department of Biomedical Engineering
`
`and Director of the Cardiovascular Laboratory in the Institute for Biomedical
`
`
`
`1
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`2 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`Engineering Research at the University of Akron where I taught graduate level
`
`courses in Biomaterials and Artificial Organs and Medical Devices. From 1975-
`
`1983, I was a Contract Manager and Senior Research Chemist at Monsanto
`
`Research Corporation at the Dayton Laboratory in Dayton, Ohio.
`
`6.
`
`I am also currently a member of the adjunct faculty at Cleveland State
`
`University and have taught courses in Biomaterials, Artificial Organs and Medical
`
`Devices, and Cardiovascular Complications of Diabetes in the doctoral Applied
`
`Biomedical Engineering Program. I have been a member of the University’s
`
`adjunct faculty since 1999.
`
`7.
`
`I obtained my Bachelors of Mechanical Engineering in 1969 from the
`
`General Motors Institute of Technology (Major Material Science). I received my
`
`Master of Science in Macromolecular Science from Case Western Reserve
`
`University. I subsequently received my Doctorate of Philosophy from Case
`
`Western Reserve University in Macromolecular Science (Major) and Operations
`
`Research (Minor) in 1974 and was a Postdoctoral Fellow on a grant from the
`
`National Heart, Lung and Blood Institute of the National Institutes of Health for a
`
`year.
`
`8. My work as an Independent Consultant at Synthetic Body Parts, Inc.
`
`relates to biomedical product development and biomaterials for both start-up
`
`companies and multi-national companies and as an expert in patent and medical
`
`
`
`2
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`3 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`implant failure litigation.
`
`9.
`
`In my roles as Senior Scientist, Director of the Polymer Laboratory
`
`and Director of R&D at AcroMed Corporation, I conducted and directed research,
`
`development, evaluation and commercialization of many metal, polymer,
`
`polymer/carbon fiber composite and elastomer material based orthopedic products,
`
`primarily for the spine.
`
`10.
`
`I am the Recipient of the 2015 C. William Hall lifetime achievement
`
`award from the Society for Biomaterials “For significant contributions to the
`
`Society for Biomaterials and an outstanding record in establishing, developing,
`
`maintaining, and promoting the objectives and goals of the Society,” received on
`
`April 2015, Charlotte, NC. I was a Delegate on the first People-to-People program
`
`on Biomaterials to the Peoples Republic of China (October 26 to November 6,
`
`2010). I am a volunteer Scientific Member of the Institutional Review Board for
`
`Human Protection (IRB) for the University Hospitals Case Medical Center of
`
`Cleveland; I have been an IRB member since June 2005. I was a member of the
`
`Edison Biotechnology Center, Omeris (State of Ohio) from 1992 through 2002, the
`
`Commercialization Cabinet from 1997-2002, the Scientific Advisory Council from
`
`1992 through 1994, and the Executive Advisory Committee from 1992-1996. I
`
`was also a member of the External Advisory Board at the Center for
`
`Cardiovascular Biomaterials, Case Western Reserve University, Cleveland, OH,
`
`
`
`3
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`4 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`from 1994 through 1998. I was also an Executive Editor (U.S.A.) of the
`
`international journal, Bio-Medical Materials and Engineering, Pergamon Press,
`
`from 1990-1996.
`
`11.
`
`I have published over 95 journal articles, book chapters, symposia,
`
`research papers and patents, most of which relate to biomaterials and spinal
`
`implants. My patents include U.S. Patent Nos. 6,669,732, entitled “Spinal Disc”,
`
`6,162,252, entitled “Artificial Spine Disc,” 5,824,094, entitled “Spinal Disc.”
`
`12.
`
`I have authored or co-authored over 75 presentations with published
`
`abstracts for national and international meetings all over the world, mostly relating
`
`to biomaterials.
`
`13. A full list of my publications, patents, book chapters, and conference
`
`presentations is included in my Curriculum Vitae (Ex. 1003).
`
`14. Exhibit 1004 is a list of the documents that I have considered in
`
`forming my opinions provided in this report. I reserve the right to supplement my
`
`opinions in the future to respond to any arguments that the Patent Owner raises and
`
`to take into account new information as it becomes available to me.
`
`
`
` OVERVIEW OF THE ’531 PATENT II.
`
`15. The ‘531 patent specification provides a method and apparatus
`
`
`
`4
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`5 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`for changing a spatial relationship between adjacent
`
`bones by inserting a wedge member into the joint
`
`between the bones. (Ex. 1001 at 1:48-50.) As
`
`depicted in Figure 2 of the ‘531 patent, the wedge
`
`member applies a force to the adjacent bones as it is
`
`moved into the joint, thus changing the spatial
`
`relationship between the bones. (Id. at 1:52-56;
`
`2:42-45; Fig. 2.) The ‘531 patent specification
`
`states that the wedge member can be used with any
`
`
`
`joints in a patient’s body, including intervertebral
`
`joints. (Id. at 2:27-28.)
`
`16. The ‘531 patent specification describes various implantable wedge
`
`members. For example, the wedge member may have a sharp leading edge as
`
`depicted above, or, as depicted in Figure 12 of the ‘531 patent (Id. at 13:60-66;
`
`Fig. 12.) The ‘531 patent provides that when the apparatus is used to change a
`
`spatial relationship between bones which are interconnected at a joint in a patient’s
`
`body, an opening is first formed in a portion of the patient’s body to expose the
`
`joint interconnecting the bones. (Id. at 1:50-52.) Then one of the bones is moved
`
`relative to the other by expanding at least a portion of the joint with a wedge
`
`member. (Id. at 1:52-54.) The wedge is subsequently moved into the joint and
`
`
`
`5
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`6 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`applies force against the bones wherein the force is then transmitted between the
`
`bones through the wedge member to maintain the joint in an expanded condition.
`
`(Id. at 1:54-59.)
`
`17. The ‘531 patent specification describes various implantable wedge
`
`members. In one disclosed embodiment depicted
`
`in Figure 5 of the ‘531 patent, the wedge member
`
`has upper and lower major side surfaces that slope
`
`towards each other and intersect at the thin end.
`
`(Id. at 6:40-43.) The ‘531 patent contemplates that
`
`
`
`a plurality of wedge members have different acute angles between the upper and
`
`lower major side surfaces to enable a surgeon to select the wedge member having a
`
`desired thickness at the thick end portions after the surgeon determines to what
`
`degree the joint should be expanded. (Id. at 6:43-52.)
`
`18. The ‘531 patent specification further describes an embodiment of a
`
`wedge member that is porous and/or has passages extending between the upper and
`
`lower surfaces in order to allow bone to grow through it. (Id. at 10:1-8; Fig. 9.)
`
`
`
`6
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`7 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`
`
`19. The ‘531 patent specification further describes an embodiment of a
`
`hollow wedge member with a compartment. (Id. at 11:11-20.) The compartment,
`
`the ‘385 patent explains, has upper and lower inner side surfaces which are smaller
`
`than the upper and lower major side surfaces of the wedge member. (Id. at 11:14-
`
`17.) The inner side surfaces, however, have the same general configuration as the
`
`upper and lower major side surfaces of the wedge member. (Id. at 11:17-20.)
`
`20. The ‘531 patent further describes that the compartment is filled with
`
`bone growth inducing material. (Id. at 11:21-22.) The ‘531 patent provides that
`
`the bone growth inducing material is positioned in the compartment through a
`
`suitable opening formed in either the upper major side surface or the lower side
`
`surfaces of the wedge member. (Id. at 11:22-26.) The specification provides
`
`examples of bone growth inducing materials to include bone morphogenic
`
`proteins and osteoinductive materials such as apatite compositions with collagen
`
`
`
`7
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`8 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`and demineralized bone. (Id. at 33-38.)
`
`21. The ‘531 patent issued with 129 claims of which independent claim
`
`105 is the only claim at issue in the Synthes Petition. Challenged Claim 105 is
`
`directed to “[a]n apparatus for use in changing the spatial relationship between first
`
`and second bones which are interconnected at a joint in a patient's body, said
`
`apparatus comprising a wedge member which is movable into the joint between the
`
`first and second bones, said wedge member having a thin end portion, a thick end
`
`portion, a first major side surface which extends from said thin end portion to said
`
`thick end portion, a second major side surface which intersects said first major side
`
`surface to form an edge at said thin end portion and extends from said thin end
`
`portion to said thick end portion, and a minor side surface which extends between
`
`said first and second major side surfaces and tapers from said thick end portion to
`
`said thin end portion, said wedge member having a plurality of passages which
`
`extend between said first and second major side surfaces for enabling bone to grow
`
`through said wedge member. (Id. at claim 105.)
`
`
`
` CLAIM CONSTRUCTION III.
`
`22.
`
`I understand that for inter partes review, claim terms are presumed to
`
`have their ordinary and customary meaning, unless the patent provides its own
`
`definition, and that claim terms will be given their broadest reasonable
`
`interpretation in view of the patent specification.
`
`8
`
`
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`9 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`23. Challenged Claim 105 is directed to an apparatus comprising a wedge
`
`member. The body of the claim contains the recitation that the wedge member “is
`
`movable into the joint between the first and second bones.” I understand from
`
`counsel that an apparatus claim, such as Challenged Claim 105, covers what a
`
`device is, not what a device does. Therefore, I understand that all of the limitations
`
`of Challenged Claim 105 are present in a prior art reference that teaches each of
`
`the claim’s structural limitations.
`
`
`
` TECHNICAL BACKGROUND IV.
`
`
`
` Anatomy of the Spine A.
`
`24. The ‘531 patent is generally directed to an implantable wedge-shaped
`
`device used for changing the spatial relationship between bones in the human
`
`body. A person of ordinary skill in the art would have understood that the field of
`
`such devices would include at least devices used in osteotomy and spinal fusion
`
`procedures.
`
`25. Osteotomy is the surgical practice in which a bone is cut to shorten,
`
`lengthen, or to change its alignment (e.g. to correct the shape of deformed bones).
`
`To change the alignment, the surgeon can either cut out and remove a wedged
`
`piece of bone and close the opening (a closing wedge osteotomy) or can insert a
`
`wedge shaped piece of bone or implant into the opening (an opening wedge
`
`osteotomy). In a closing wedge osteotomy, the resulting site has bone on bone
`
`
`
`9
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`10 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`contact and can fuse directly. In an opening wedge osteotomy, the wedge shaped
`
`implant can be filled with bone marrow, bone chips or other bone inducing
`
`materials to promote bone formation and fusion. This procedure was well-known
`
`to a person of ordinary skill in the art as of August 20, 1998.
`
`26. The spine extends from the base of the skull to the tail bone or coccyx
`
`and consists of bones called vertebrae. Each vertebrae is separated from the
`
`adjacent vertebrae, either above or below, by an intervertebral disc that consists of
`
`an outside annulus made primarily from collagen fiber and an inside made of a gel
`
`like material. The top and bottom of the disc space are the adjacent vertebral
`
`bodies. The vertebral bodies are bony structures with a softer and vascular
`
`cancellous bone interior and a harder cortical bone shell. There are 23
`
`intervertebral discs in the human body: six in the cervical region (i.e., neck), 12 in
`
`the thoracic region (i.e., middle back), and five in the lumbar region (i.e., lower
`
`back), which includes the disc between the lowest lumbar vertebral body (L5) and
`
`the top of the sacrum (S1). The intervertebral discs of the spine provide flexibility
`
`and some cushion from shock. The flexibility includes flexion (bending forward),
`
`extension (bending backward), and lateral bending (bending sideways), with
`
`different ranges of motion for each level of the spine.
`
`27.
`
`In a normal standing position, the spine is not straight, but has a
`
`curved nature. The normal curvature of the normal spine consists of lordosis
`
`
`
`10
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`11 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`(segments creating a backward leaning curve) in the cervical region, kyphosis
`
`(segments creating a forward leaning curve) in the thoracic region and lordosis
`
`again in the lumbar region and is generated by both wedge shaped vertebral bodies
`
`and wedge shaped spinal discs.
`
`
`
`The wedge shape of the spinal discs is different at different levels of the spine. For
`
`example, both the lumbar disc space of L4-L5 (the most commonly operated
`
`lumbar disc space between vertebral body L4 and vertebral body L5) and the disc
`
`space L5-S1 (the second most commonly operated lumbar disc space between
`
`vertebral body L5 and the top of the sacrum, S1) have been reported to have a
`
`normal angle of 11 degrees of lordosis.1 Cervical disc spaces are typically between
`
`
`1 Wambolt A, Spencer DL, “Analyses of the Distribution of the Lumbar Lordosis
`
`
`
`11
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`12 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`2 degrees to 10 degrees of lordosis.2 The loss of normal lordosis causes pain as
`
`muscles and joints are put under stresses for which they were not designed.
`
`28. The overall curved shape of the spine is important. However, the
`
`spine can become damaged as a result of degeneration, dysfunction, disease,
`
`trauma, and age. In patients with spine degeneration, the spine may exhibit
`
`abnormal curvature, abnormal alignment of the vertebrae and/or general deformity
`
`due to the thinning or collapse of the spinal discs. These conditions may lead to
`
`nerve compression, disability and overall instability and pain. Surgical
`
`intervention may be required to correct spinal anomalies and may involve
`
`realigning of vertebrae and/or stopping the motions that generate pain (e.g. by
`
`fusion) or creating more normal motions (e.g. by functional artificial spinal discs).
`
`29. One medical condition sometimes resulting from degeneration of the
`
`spine or scoliosis is flat back syndrome. In patients with flat back syndrome, the
`
`normal lordosis curvature of the spine is lost and the patients need to bend forward
`
`
`
`in the Normal Spine. 11(1) ORTHOP TRANS. 92-3 (1987) (the L1-L2 disc space has
`
`also been reported to have an angle of 6 degrees of lordosis).
`
`2 Lu J et al., “Anatomic Bases for Anterior Spinal Surgery: Surgical Anatomy of
`
`the Cervical Vertebral Body and Disc Space,” 21(4) SURG. RADIOL. ANAT.
`
`235-39 (1999)
`
`
`
`12
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`13 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`in order to stand upright. Over time, this abnormal posture causes pain as muscles
`
`and joints are put under stresses for which they were not designed. Surgeries are
`
`sometimes conducted to restore the normal curvature of the spine. 3
`
`30. A common treatment for a variety of spinal disorders is spinal fusion.
`
`Spinal fusion combines two vertebral bodies and the intervening disc into one large
`
`bone. A spacer such as a fusion cage or an allograft is most often used to assure
`
`that there is room in the center of the now fused together vertebral bodies for the
`
`nerves to exit from the spinal cord to the rest of the body without being crushed.
`
`Where spinal fusion occurs in a section of the spine with significant lordosis, the
`
`normal curvature of the spine in that area is typically restored.
`
`31.
`
`Intervertebral implants in these curved regions of the spine are
`
`therefore typically wedge-shaped to restore and maintain lordosis, the normal
`
`curvature of the spine. Wedge-shaped cages significantly increase segmental
`
`lordosis, enhance lumbar lordosis, and are preferred for restoring sagittal alignment
`
`in instrumented posterior lumbar interbody fusion procedures.4
`
`
`
`3 Kostuik JP et al., “Combined Single Stage Anterior and Posterior Osteotomy for
`
`Correction of Iatrogenic Lumbar Kyphosis,” 13(3) SPINE 257-66 (Mar. 1988).
`
`4 Gödde S et al., “Influence of Cage Geometry on Sagittal Alignment in
`
`Instrumented Posterior Lumbar Interbody Fusion,” 28(15) SPINE 11693-99 (Aug.
`
`
`
`13
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`14 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`
`B.
`
`Spine Fusion Was A Common Procedure in 1998
`
`32. As of August 20, 1998, the use of spinal implants to stabilize and fuse
`
`vertebrae to relieve pain and correct deformities in patients with various forms of
`
`spinal degeneration was common practice. As early as the 1950s, decompression –
`
`the removal of the intervertebral disc located between adjacent vertebrae – together
`
`with the implantation of a bone graft in the resulting space had been established as
`
`a standard method of accomplishing stabilization and fusion.5
`
`33. Between 1990 and 1998, over one million spinal fusions were
`
`performed in hospitals throughout the U.S. Of the 112,000 spinal fusions
`
`performed in U.S. hospitals in 1990, 50% were cervical fusions, 35% were lumbar
`
`9% were thoracic, and 6% were for refusions or unspecified. In 1998, over
`
`174,000 spine fusions were performed.6
`
`
`C.
`
`Spinal Implant Design and Spinal Implant Materials
`
`
`
`1, 2003).
`
`5 Cloward RB, “The Treatment of Ruptured Lumbar Intervertebral Discs by
`
`Vertebral Body Fusion,” 10(2) J. NEUROSURGERY 154-68 (March 1953).
`
`6 "Spinal Implants: The Next Orthopedic Growth Market," 3 (3) Orthopedic
`
`Network News 1-5 (July 1992); Rajaee, SS, et al., “Spinal Fusion in the United
`
`States, Analysis of Trends From 1998 to 2008,” 37(1) SPINE 67-76 (2012).
`
`
`
`14
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`15 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`34. As of August 20, 1998, spinal implants had long been designed in a
`
`variety of shapes and sizes to fit the specific implantation site and to accomplish
`
`the needed correction, and manufactured in a variety of materials.
`
`35. For example, it was common to provide wedge-shaped intervertebral
`
`disc replacements with a variety of angles to match the natural disc angles so as to
`
`restore and maintain lordosis. For cervical spine implants, such implants may be
`
`longer than they are wide or wider than they are long – depending on surgeon
`
`preference on how much bone to remove on the sides. For lumbar spine implants,
`
`such implants are commonly wider than they are long. Moreover, some implants
`
`were designed with a thick wall between the anterior face and a central opening in
`
`order to provide additional material for inserter tools to hold the implant and more
`
`strength to allow the implant to be inserted and adjusted within the disc space. The
`
`thicker wall also provides more surface area to contact the hard cortical bone of the
`
`anterior sides of the superior and inferior vertebrae for load bearing and to inhibit
`
`subsidence.
`
`36. Furthermore, spinal implants designed to fuse two vertebrae typically
`
`contained one or more passages for insertion of bone graft material through which
`
`bone growth could occur. The illustration below shows a wedge-shaped vertical
`
`ring implant with two openings for bone graft material that was in use in the early
`
`
`
`15
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`16 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`1990s.7 As seen, the central rib reduces the amount of bone graft that can be used,
`
`but provides more surface area to help resist subsidence, strengthens the implant
`
`and provides additional material for the anterior face screw hole for the inserter.
`
`Fig. 2 of Weiner
`
`
`
`37. Michelson also discloses an opening for bone graft material. (U.S.
`
`Patent No. 5,609,635 (“Michelson”).) Michelson discloses an interbody spinal
`
`fusion implant configured to restore and maintain two adjacent vertebrae of the
`
`spine to correct anatomical angular relationship. (Id. at 1:18-21.) Specifically,
`
`Michelson discloses that the spinal fusion implants have a structural configuration
`
`that provides for the maintaining and creating of the normal anatomic angular
`
`relationship of two adjacent vertebrae of the spine to maintain and create spinal
`
`
`
`7 Weiner BK and Fraser RD, “Spine Update Lumbar Interbody Cages,” 23(5)
`
`SPINE 634-640 (1998).
`
`
`
`16
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`17 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`lordosis. (Id. at 1: 57-61.) The spinal fusion implants have upper and lower
`
`surfaces that are in a converging angular relationship to each other such that the
`
`implants have an overall wedge-shaped. (Id. at 2: 1-5.) Michelson further teaches
`
`that the implant is hollow and comprises a plurality of openings passing through
`
`the upper and lower surfaces and into a central hollow chamber. (Id. at 6: 56-59.)
`
`The internal hollow chamber can be filled with osteoconductive, osteoinductive,
`
`osteogenic and other fusion enhancing materials such as bone or bone growth
`
`inducing material such as hydroxyapatite, hydroxyapatite tricalcium phosphate or
`
`bone morphogenic protein. (Id. at 7: 19-25.)
`
`38. Pavlov discloses a wedge-shaped fusion cage that is shaped by the
`
`normal lordosis of the vertebral bone structures and the conically-shaped body can
`
`be sized and selected in order to maintain or enlarge upon the normal lordosis.
`
`(U.S. Patent No. 5,906,616 (“Pavlov”), 2:9-16.) Pavolv provides that the fusion
`
`cage has an internal cavity wherein bone growth inducing substances, such as
`
`bone chips, can be placed either before the fusion cage is inserted or after the
`
`fusion cage is inserted. (Id. at 2:62-66.)
`
`39. Stainless steel has long been used for implants and since the early
`
`1990s, additional metals such titanium became more common. A problem with
`
`metals, however, is that they inhibit imaging by blocking x-rays and cause
`
`imaging artifacts by bending magnetic fields. This makes post-operation
`
`
`
`17
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`18 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`assessment of fusion or tumor recurrence more difficult. In addition, the very
`
`high stiffness of metals means that metallic implants carry almost all of the
`
`mechanical loads from the top surface of the implant to the bottom surface of the
`
`implant and do not allow the surrounding bone to flex, bend, or compress. This
`
`discourages bone growth and hence fusion.
`
`40. Also in the early 1990s, therefore, polymeric materials (biocompatible
`
`plastics) were put to use for orthopedic applications. Commonly used polymeric
`
`materials at this time include poly(ether ether ketone) (PEEK) and poly(ether
`
`ketone ether ketone ketone) (PEKEKK), and carbon fiber filled forms of these
`
`polymers, and were used since the early 1990s for interbody fusion cages.
`
`41. Because the bone growth necessary for spinal fusion occurs best when
`
`the bone is under a dynamic load, compressible implants are optimal for promoting
`
`spinal fusion. Certain polymeric materials were known to be both rigid and strong
`
`enough to support a patient’s weight and compressible so as to encourage fusion.
`
`42.
`
`Polymeric materials were both radio translucent and less stiff than
`
`metals. Polymeric materials also permit assessment of fusions using radiographs,
`
`computed tomography scans or magnetic resonance imaging.
`
`
`D.
`
`Fixation of Spine Implants
`
`43. By 1998 it had long been understood that spinal fusion implants must
`
`be fixed in place between vertebrae in order for fusion to occur. With the anterior
`
`
`
`18
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`19 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`longitudinal ligament and the disc annulus cut, the forces applied on the implanted
`
`device by the spine could otherwise move the implant out of place or even eject it
`
`from the cavity. Even local micromotion at the interface of the implant and the
`
`bone must be minimized for fusion to occur. Fixing the implant in place also
`
`maintains the alignment of the spine around the implant.
`
`44. The earliest and most common method of fixation was the use of
`
`screws. One early method was using two cancellous bone screws and washers to
`
`secure a wedge-shaped intervertebral implant to the vertebrae.
`
`45. Another common fixation method was screwing a metal plate, strip or
`
`rod to the vertebrae as shown below:8
`
`Figure 11 of U.S. Patent No. 4,743,256
`
`46. Metal was a preferred material for fixation components due to its high
`
`
`
`strength and stiffness.
`
`
`
`8 U.S. Patent No. 4,743,256.
`
`
`
`19
`
`DePuy Synthes Products, Inc. & DePuy Synthes Sales, Inc.
`Exhibit 1002
`20 of 48
`
`

`
`Declaration of Carl R. McMillin, Ph.D., in Support of DePuy Synthes Sales, Inc.
`and DePuy Synthes Products, LLC Petition – IPR of U.S. Patent No. 6,099,531
`
`47. For example, Doty discloses a vertebral body prosthesis made of a
`
`bio-compatible material such as metal or plastic that approximates the dimension
`
`of one human vertebral body. (U.S. Patent No. 4,599, 086 (“Doty”), 3:15-18.)
`
`Doty also discloses that the prosthesis has a biocompatible metal retaining plate
`
`which overlaps two vertebral bodies and is secured via screws to fasten the plate to
`
`the bony structure of the vertebral bodies. (Id. at 4:49-58.) Doty further discloses
`
`that the prosthesis contains a spacer member in a variety of different widths to
`
`accommodate different spinal configurations with each spacer measuring various
`
`fractions of a vertebral body and/or vertebral interspace. (Id. at 5: 6-10.)
`
`48. Salib also discloses a method of fixation. (U.S. Patent No. 5,258,031
`
`(“Salib”).) Salib discloses a surgical joint replacement device for replacement of a
`
`ruptured disk between consecutive vertebrae in the spine. (Id. at 1:8-10.) Salib
`
`states that the device has an upper assembly and a lower assembly (id. at 3:22-23)
`
`and is to be implanted between a first vertebral body above it and a second
`
`vertebral body below it (id. at 3:15-18). The upper assembly includes a first
`
`member having a socket (id. at 3:24-25) while the lower assembly includes a
`
`second member having a ball that fits loosely into the socket of the upper assembly
`
`(id. at 3:46-48). Salib describes that the first and second members have a base
`
`plate with a tab that includes an opening therethrough so that a screw can be used
`
`to fasten the assembly t

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket